Diskriminace v pracovním prostředí

Box and whisker plots representing the expression of a) miR-15b b) miR-16  c) miR-20a d) miR-27b e) miR-128a f) miR-130a g) miR-192 h) miR-221 i) miR-222 j) miR-let7f in PB lymphocytes in patients in radiological stages I vs. II-IV (JPEG 4059 kb

Additional file 1: of The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD

Detailed Method description. (PDF 118 kb

Additional file 5: of The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD

Figure E2. Circulating (A) and sputum (B) hemopoietic progenitor cells (HPC) in patients with and without sputum eosinophilia. **p < 0.01. (PDF 56 kb

Additional file 4: of The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD

Table E1. Correlations between serum and sputum IL-33 and sST2, ST2 mRNA and clinical parameters in COPD. FEV1 – forced expiratory volume in first second; FVC – forced vital capacity; CAT – COPD assessment test; 6MWT – six-minute walk test; mMRC – modified Medical Research Council dyspnea scale. (PDF 39 kb

Additional file 2: of The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD

Figure E4. Hemopoietic progenitor cells gating strategy. (PDF 88 kb

Additional file 8:Figure S8. of Altered miRNA expression in pulmonary sarcoidosis

Box and whisker plots representing the expression of a) miR-15b b) miR-16 c) miR-20a d) miR-27b e) miR-128a f) miR-130a  g) miR-192 h) miR-221 i) miR-222 j) miR-let7f in PB lymphocytes in patients with acute vs. insidious form of disease. (JPEG 4053 kb

Additional file 5:Figure S5. of Altered miRNA expression in pulmonary sarcoidosis

Box and whisker plots representing the expression of a) miR-15b b) miR-16 c) miR-20a d) miR-27b e) miR128 f) miR-130a  g) miR-192 h) miR-221 i) miR-221 j) miR-let7f  in BALF cells in patients with normal vs.abnormal spirometry (JPEG 4306 kb

Additional file 2:Figure S2. of Altered miRNA expression in pulmonary sarcoidosis

Box and whisker plots, presenting a) miR-16 b) miR-20a c) miR-128a expression mean values in PB lymphocytes of patients and controls. (JPEG 1357 kb

Additional file 4:Figure S4. of Altered miRNA expression in pulmonary sarcoidosis

Box and whisker plots representing the expression of a) miR-15b b) miR-16 c) miR-20a d) miR-27b e) miR128 f) miR-130a g) miR-192 h) miR-221 i) miR-222 j) miR-let7f  in BALF cells in patients with the acute vs. insidious form of disease. (JPEG 4285 kb

Additional file 3:Figure S3. of Altered miRNA expression in pulmonary sarcoidosis

Box and whisker plots representing the expression of a) miR-15b b) miR-16 c) d) miR-27b, miR-20a e) miR128 f) miR-130a g) miR-192 h) miR-221 i) miR-222 j) miR-let7f  in BALF cells in patients in radiological stags I vs. II-IV (JPEG 4235 kb